Skip to main content

Blood Culture Negative Endocarditis

  • Chapter
  • First Online:
Book cover Endocarditis

Abstract

Blood culture negative endocarditis is defined as definite or probable endocarditis in which three or more aerobic and anaerobic blood cultures collected over 48 h remain negative despite prolonged (greater than 1 week) incubation. Culture negative endocarditis constitutes a significant percentage of all cases of endocarditis in an institution and is a particularly challenging condition for the clinician treating such a patient. An organized approach to diagnosis and treatment is necessary. The most common cause of culture negative endocarditis is prior antibiotic therapy but an increasing number of organisms that cannot be grown in blood cultures given current techniques account for a varying percentage of cases depending on geographic location and laboratory technology. Nucleic acid amplification techniques, immunohistochemistry and transmission electron microscopy on vegetations all have a role in making a diagnosis. In hospital mortality is similar to that of culture positive endocarditis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Murashita T, et al. Surgical results for active endocarditis with prosthetic valve replacement: impact of culture-negative endocarditis on early and late outcomes. Eur J Cardiothorac Surg. 2004;26(6):1104–11.

    Article  PubMed  Google Scholar 

  2. Zamorano J, et al. Differences between endocarditis with true negative blood cultures and those with previous antibiotic treatment. J Heart Valve Dis. 2003;12(2):256–60.

    PubMed  Google Scholar 

  3. Lepidi H, Durack DT, Raoult D. Diagnostic methods current best practices and guidelines for histologic evaluation in infective endocarditis. Infect Dis Clin North Am. 2002;16(2):339–61. ix.

    Article  PubMed  Google Scholar 

  4. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke endocarditis service. Am J Med. 1994;96(3):200–9.

    Article  CAS  PubMed  Google Scholar 

  5. Watanakunakorn C, Burkert T. Infective endocarditis at a large community teaching hospital, 1980–1990. A review of 210 episodes. Medicine (Baltimore). 1993;72(2):90–102.

    Article  CAS  Google Scholar 

  6. Werner M, et al. A clinical study of culture-negative endocarditis. Medicine (Baltimore). 2003;82(4):263–73.

    Google Scholar 

  7. Siciliano RF, et al. Community-acquired culture-negative endocarditis: clinical characteristics and risk factors for mortality. Int J Infect Dis. 2014;25:191–5.

    Article  PubMed  Google Scholar 

  8. Hoen B, et al. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA. 2002;288(1):75–81.

    Article  PubMed  Google Scholar 

  9. Podglajen I, et al. Comparative molecular and microbiologic diagnosis of bacterial endocarditis. Emerg Infect Dis. 2003;9(12):1543–7.

    PubMed  PubMed Central  Google Scholar 

  10. Zamorano J, et al. Comparison of outcome in patients with culture-negative versus culture-positive active infective endocarditis. Am J Cardiol. 2001;87(12):1423–5.

    Article  CAS  PubMed  Google Scholar 

  11. Krcmery V, Hricak V, Babelova O. Culture negative endocarditis: analysis of 201 cases. Scand J Infect Dis. 2007;39(4):384.

    Article  PubMed  Google Scholar 

  12. Siddiqui BK, et al. Impact of prior antibiotic use in culture-negative endocarditis: review of 86 cases from southern Pakistan. Int J Infect Dis. 2009;13(5):606–12.

    Article  PubMed  Google Scholar 

  13. Ferrera C, et al. Reassessment of blood culture-negative endocarditis: its profile is similar to that of blood culture-positive endocarditis. Rev Esp Cardiol. 2012;65(10):891–900.

    Article  PubMed  Google Scholar 

  14. Brouqui P, Raoult D. Endocarditis due to rare and fastidious bacteria. Clin Microbiol Rev. 2001;14(1):177–207.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Webb R, et al. Infective endocarditis in New Zealand children 1994–2012. Pediatr Infect Dis J. 2014;33(5):437–42.

    Article  PubMed  Google Scholar 

  16. Powell EA, et al. Application of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of the fastidious pediatric pathogens Aggregatibacter, Eikenella, Haemophilus, and Kingella. J Clin Microbiol. 2013;51(11):3862–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Houpikian P, Raoult D. Blood culture-negative endocarditis in a reference center: etiologic diagnosis of 348 cases. Medicine (Baltimore). 2005;84(3):162–73.

    Article  Google Scholar 

  18. Fournier PE, et al. Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective study of 819 new cases. Clin Infect Dis. 2010;51(2):131–40.

    Article  CAS  PubMed  Google Scholar 

  19. Geissdorfer W, et al. High frequency of Tropheryma whipplei in culture-negative endocarditis. J Clin Microbiol. 2012;50(2):216–22.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  20. Slipczuk L, et al. Infective endocarditis epidemiology over five decades: a systematic review. PLoS One. 2013;8(12):e82665.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  21. Pazin GJ, Saul S, Thompson ME. Blood culture positivity: suppression by outpatient antibiotic therapy in patients with bacterial endocarditis. Arch Intern Med. 1982;142(2):263–8.

    Article  CAS  PubMed  Google Scholar 

  22. Walsh MG. Assessing Q fever in a representative sample from the United States population: identification of a potential occupational hazard. Epidemiol Infect. 2012;140(1):42–6.

    Article  CAS  PubMed  Google Scholar 

  23. Foucault C, Brouqui P, Raoult D. Bartonella quintana characteristics and clinical management. Emerg Infect Dis. 2006;12(2):217–23.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Lamas CC, Eykyn SJ. Blood culture negative endocarditis: analysis of 63 cases presenting over 25 years. Heart. 2003;89(3):258–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Werner M, et al. A 10-year survey of blood culture negative endocarditis in Sweden: aminoglycoside therapy is important for survival. Scand J Infect Dis. 2008;40(4):279–85.

    Article  PubMed  Google Scholar 

  26. Albrich WC, et al. A mechanic with a bad valve: blood-culture-negative endocarditis. Lancet Infect Dis. 2004;4(12):777–84.

    Article  PubMed  Google Scholar 

  27. Houpikian P, Raoult D. Diagnostic methods. Current best practices and guidelines for identification of difficult-to-culture pathogens in infective endocarditis. Cardiol Clin. 2003;21(2):207–17.

    Article  PubMed  Google Scholar 

  28. Washington 2nd JA. The role of the microbiology laboratory in the diagnosis and antimicrobial treatment of infective endocarditis. Mayo Clin Proc. 1982;57(1):22–32.

    PubMed  Google Scholar 

  29. Wang C-Y, et al. Invasive infections of Aggregatibacter (Actinobacillus) actinomycetemcomitans. J Microbiol Immunol Infect. 2010;43(6):491–7.

    Article  PubMed  Google Scholar 

  30. Bouvet A. Human endocarditis due to nutritionally variant streptococci: streptococcus adjacens and Streptococcus defectivus. Eur Heart J. 1995;16(Suppl B):24–7.

    Article  PubMed  Google Scholar 

  31. Christensen JJ, Gruhn N, Facklam RR. Endocarditis caused by Abiotrophia species. Scand J Infect Dis. 1999;31(2):210–2.

    Article  CAS  PubMed  Google Scholar 

  32. Agan BK, Dolan MJ. Laboratory diagnosis of Bartonella infections. Clin Lab Med. 2002;22(4):937–62.

    Article  PubMed  Google Scholar 

  33. Marrie TJ, Raoult D. Update on Q fever, including Q fever endocarditis. Curr Clin Top Infect Dis. 2002;22:97–124.

    PubMed  Google Scholar 

  34. Raoult D, et al. Cultivation of the bacillus of Whipple’s disease. N Engl J Med. 2000;342(9):620–5.

    Article  CAS  PubMed  Google Scholar 

  35. Shapiro DS, et al. Brief report: Chlamydia psittaci endocarditis diagnosed by blood culture. N Engl J Med. 1992;326(18):1192–5.

    Article  CAS  PubMed  Google Scholar 

  36. Holler JG, et al. Using MALDI-TOF mass spectrometry as a rapid and accurate diagnostic tool in infective endocarditis: a case report of a patient with mitral valve infective endocarditis caused by Abiotrophia defectiva. Scand J Infect Dis. 2011;43(3):234–7.

    Article  PubMed  Google Scholar 

  37. Jonckheere S, et al. Prosthetic valve endocarditis caused by Bordetella holmesii, an Acinetobacter lookalike. J Med Microbiol. 2012;61(Pt 6):874–7.

    Article  PubMed  Google Scholar 

  38. Wallet F, et al. Rapid identification of Cardiobacterium hominis by MALDI-TOF mass spectrometry during infective endocarditis. Jpn J Infect Dis. 2011;64(4):327–9.

    PubMed  Google Scholar 

  39. Li JS, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30(4):633–8.

    Article  CAS  PubMed  Google Scholar 

  40. Woods GL, Walker DH. Detection of infection or infectious agents by use of cytologic and histologic stains. Clin Microbiol Rev. 1996;9(3):382–404.

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Relman DA, et al. Identification of the uncultured bacillus of Whipple’s disease. N Engl J Med. 1992;327(5):293–301.

    Article  CAS  PubMed  Google Scholar 

  42. Eck M, et al. Invasion and destruction of mucosal plasma cells by Tropheryma whippelii. Hum Pathol. 1997;28(12):1424–8.

    Article  CAS  PubMed  Google Scholar 

  43. Fournier PE, Raoult D. Nonculture laboratory methods for the diagnosis of infectious endocarditis. Curr Infect Dis Rep. 1999;1(2):136–41.

    Article  PubMed  Google Scholar 

  44. Lepidi H, Fournier PE, Raoult D. Quantitative analysis of valvular lesions during Bartonella endocarditis. Am J Clin Pathol. 2000;114(6):880–9.

    Article  CAS  PubMed  Google Scholar 

  45. Harris KA, et al. Service evaluation to establish the sensitivity, specificity and additional value of broad-range 16S rDNA PCR for the diagnosis of infective endocarditis from resected endocardial material in patients from eight UK and Ireland hospitals. Eur J Clin Microbiol Infect Dis. 2014;33:2061–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Isotalo PA, et al. Prosthetic valve fungal endocarditis due to histoplasmosis. Can J Cardiol. 2001;17(3):297–303.

    CAS  PubMed  Google Scholar 

  47. Brouqui P, Dumler JS, Raoult D. Immunohistologic demonstration of Coxiella burnetii in the valves of patients with Q fever endocarditis. Am J Med. 1994;97(5):451–8.

    Article  CAS  PubMed  Google Scholar 

  48. Thiele D, Karo M, Krauss H. Monoclonal antibody based capture ELISA/ELIFA for detection of Coxiella burnetii in clinical specimens. Eur J Epidemiol. 1992;8(4):568–74.

    Article  CAS  PubMed  Google Scholar 

  49. Raoult D, Laurent JC, Mutillod M. Monoclonal antibodies to Coxiella burnetii for antigenic detection in cell cultures and in paraffin-embedded tissues. Am J Clin Pathol. 1994;101(3):318–20.

    CAS  PubMed  Google Scholar 

  50. Curry A. Electron microscopy as a tool for identifying new pathogens. J Infect. 2000;40(2):107–15.

    Article  CAS  PubMed  Google Scholar 

  51. Fournier PE, et al. Modification of the diagnostic criteria proposed by the Duke endocarditis service to permit improved diagnosis of Q fever endocarditis. Am J Med. 1996;100(6):629–33.

    Article  CAS  PubMed  Google Scholar 

  52. Maurin M, et al. Serological cross-reactions between Bartonella and Chlamydia species: implications for diagnosis. J Clin Microbiol. 1997;35(9):2283–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  53. Rantakokko-Jalava K, et al. Direct amplification of rRNA genes in diagnosis of bacterial infections. J Clin Microbiol. 2000;38(1):32–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  54. Lang S, et al. Evaluation of PCR in the molecular diagnosis of endocarditis. J Infect. 2004;48(3):269–75.

    Article  CAS  PubMed  Google Scholar 

  55. Breitkopf C, et al. Impact of a molecular approach to improve the microbiological diagnosis of infective heart valve endocarditis. Circulation. 2005;111(11):1415–21.

    Article  CAS  PubMed  Google Scholar 

  56. Voldstedlund M, et al. Broad-range PCR and sequencing in routine diagnosis of infective endocarditis. APMIS. 2008;116(3):190–8.

    Article  PubMed  Google Scholar 

  57. Relman DA. The search for unrecognized pathogens. Science. 1999;284(5418):1308–10.

    Article  CAS  PubMed  Google Scholar 

  58. Munoz P, et al. Heart valves should not be routinely cultured. J Clin Microbiol. 2008;46(9):2897–901.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Millar BC, Moore JE. Current trends in the molecular diagnosis of infective endocarditis. Eur J Clin Microbiol Infect Dis. 2004;23(5):353–65.

    Article  CAS  PubMed  Google Scholar 

  60. Calabrese F, Carturan E, Thiene G. Cardiac infections: focus on molecular diagnosis. Cardiovasc Pathol. 2010;19(3):171–82.

    Article  PubMed  Google Scholar 

  61. Kotilainen P, et al. Aetiological diagnosis of infective endocarditis by direct amplification of rRNA genes from surgically removed valve tissue. An 11-year experience in a Finnish teaching hospital. Ann Med. 2006;38(4):263–73.

    Article  CAS  PubMed  Google Scholar 

  62. Madico GE, Rice PA. 16S-ribosomal DNA to diagnose culture-negative endocarditis. Curr Infect Dis Rep. 2008;10(4):280–6.

    Article  PubMed  Google Scholar 

  63. Gould FK, et al. Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the working party of the British society for antimicrobial chemotherapy. J Antimicrob Chemother. 2012;67(2):269–89.

    Article  CAS  PubMed  Google Scholar 

  64. Shin GY, et al. Molecular technique identifies the pathogen responsible for culture negative infective endocarditis. Heart. 2005;91(6):e47.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Madershahian N, et al. Polymerase chain reaction amplification as a diagnostic tool in culture-negative multiple-valve endocarditis. Ann Thorac Surg. 2005;79(3):e21–2.

    Article  PubMed  Google Scholar 

  66. Benitez-Paez A, et al. Detection of transient bacteraemia following dental extractions by 16S rDNA pyrosequencing: a pilot study. PLoS One. 2013;8(3):e57782.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Gami AS, et al. Q fever endocarditis in the United States. Mayo Clin Proc. 2004;79(2):253–7.

    Article  PubMed  Google Scholar 

  68. Raoult D, et al. Q fever 1985–1998. Clinical and epidemiologic features of 1,383 infections. Medicine (Baltimore). 2000;79(2):109–23.

    Article  CAS  Google Scholar 

  69. Hackert VH, et al. Q fever: single-point source outbreak with high attack rates and massive numbers of undetected infections across an entire region. Clin Infect Dis. 2012;55(12):1591–9.

    Article  PubMed  Google Scholar 

  70. Schneeberger PM, et al. Q fever in the Netherlands – 2007–2010: what we learned from the largest outbreak ever. Med Mal Infect. 2014;44(8):339–53.

    Article  CAS  PubMed  Google Scholar 

  71. Kampschreur LM, et al. Chronic Q fever in the Netherlands 5 years after the start of the Q fever epidemic: results from the Dutch chronic Q fever database. J Clin Microbiol. 2014;52(5):1637–43.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Stein A, Raoult D. Q fever endocarditis. Eur Heart J. 1995;16(Suppl B):19–23.

    Article  PubMed  Google Scholar 

  73. Vacher-Coponat H, et al. Proliferative glomerulonephritis revealing chronic Q fever. Am J Nephrol. 1996;16(2):159–61.

    Article  CAS  PubMed  Google Scholar 

  74. Lepidi H, et al. Cardiac valves in patients with Q fever endocarditis: microbiological, molecular, and histologic studies. J Infect Dis. 2003;187(7):1097–106.

    Article  PubMed  Google Scholar 

  75. Rolain JM, Lecam C, Raoult D. Simplified serological diagnosis of endocarditis due to Coxiella burnetii and Bartonella. Clin Diagn Lab Immunol. 2003;10(6):1147–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  76. Stein A, Raoult D. Detection of Coxiella burnetti by DNA amplification using polymerase chain reaction. J Clin Microbiol. 1992;30(9):2462–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  77. Merhej V, et al. Relevance of the positron emission tomography in the diagnosis of vascular graft infection with Coxiella burnetii. Comp Immunol Microbiol Infect Dis. 2012;35(1):45–9.

    Article  PubMed  Google Scholar 

  78. Hoen B, et al. Infective endocarditis in patients with negative blood cultures: analysis of 88 cases from a one-year nationwide survey in France. Clin Infect Dis. 1995;20(3):501–6.

    Article  CAS  PubMed  Google Scholar 

  79. Raoult D, et al. Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine. Arch Intern Med. 1999;159(2):167–73.

    Article  CAS  PubMed  Google Scholar 

  80. Levy PY, et al. Comparison of different antibiotic regimens for therapy of 32 cases of Q fever endocarditis. Antimicrob Agents Chemother. 1991;35(3):533–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Fenollar F, et al. Endocarditis after acute Q fever in patients with previously undiagnosed valvulopathies. Clin Infect Dis. 2006;42(6):818–21.

    Article  PubMed  Google Scholar 

  82. Maguina C, Gotuzzo E. Bartonellosis. New and old. Infect Dis Clin North Am. 2000;14(1):1–22. vii.

    Article  CAS  PubMed  Google Scholar 

  83. Avidor B, et al. Bartonella koehlerae, a new cat-associated agent of culture-negative human endocarditis. J Clin Microbiol. 2004;42(8):3462–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Raoult D, et al. First isolation of Bartonella alsatica from a valve of a patient with endocarditis. J Clin Microbiol. 2006;44(1):278–9.

    Article  PubMed  PubMed Central  Google Scholar 

  85. Fournier PE, et al. Epidemiologic and clinical characteristics of Bartonella quintana and Bartonella henselae endocarditis: a study of 48 patients. Medicine (Baltimore). 2001;80(4):245–51.

    Article  CAS  Google Scholar 

  86. Shapira N, et al. Latent infective endocarditis: epidemiology and clinical characteristics of patients with unsuspected endocarditis detected after elective valve replacement. Ann Thorac Surg. 2004;78(5):1623–9.

    Article  PubMed  Google Scholar 

  87. Raoult D, et al. Outcome and treatment of Bartonella endocarditis. Arch Intern Med. 2003;163(2):226–30.

    Article  PubMed  Google Scholar 

  88. Prutsky G, et al. Treatment outcomes of human bartonellosis: a systematic review and meta-analysis. Int J Infect Dis. 2013;17(10):e811–9.

    Article  PubMed  Google Scholar 

  89. Fernandez-Guerrero ML. Zoonotic endocarditis. Infect Dis Clin North Am. 1993;7(1):135–52.

    CAS  PubMed  Google Scholar 

  90. Benslimani A, et al. Bacterial zoonoses and infective endocarditis. Algeria Emerg Infect Dis. 2005;11(2):216–24.

    Article  PubMed  Google Scholar 

  91. Reguera JM, et al. Brucella endocarditis: clinical, diagnostic, and therapeutic approach. Eur J Clin Microbiol Infect Dis. 2003;22(11):647–50.

    Article  CAS  PubMed  Google Scholar 

  92. Peery TM, Belter LF. Brucellosis and heart disease. II. Fatal brucellosis: a review of the literature and report of new cases. Am J Pathol. 1960;36:673–97.

    CAS  PubMed  PubMed Central  Google Scholar 

  93. Al Dahouk S, et al. Laboratory-based diagnosis of brucellosis – a review of the literature. Part II: serological tests for brucellosis. Clin Lab. 2003;49(11–12):577–89.

    PubMed  Google Scholar 

  94. Drancourt M, Brouqui P, Raoult D. Afipia clevelandensis antibodies and cross-reactivity with Brucella spp. and Yersinia enterocolitica O:9. Clin Diagn Lab Immunol. 1997;4(6):748–52.

    CAS  PubMed  PubMed Central  Google Scholar 

  95. Koruk ST, et al. Management of Brucella endocarditis: results of the Gulhane study. Int J Antimicrob Agents. 2012;40(2):145–50.

    Article  CAS  PubMed  Google Scholar 

  96. Cohen N, et al. Conservative treatment for Brucella endocarditis. Clin Cardiol. 1997;20(3):291–4.

    Article  CAS  PubMed  Google Scholar 

  97. Turhan V, et al. Is antimicrobial treatment alone sufficient for Brucella endocarditis, and if it is, which antibiotics should we use? Int J Antimicrob Agents. 2013;41(2):201–2.

    Article  CAS  PubMed  Google Scholar 

  98. Pierrotti LC, Baddour LM. Fungal endocarditis, 1995–2000. Chest. 2002;122(1):302–10.

    Article  PubMed  Google Scholar 

  99. Ellis ME, et al. Fungal endocarditis: evidence in the world literature, 1965–1995. Clin Infect Dis. 2001;32(1):50–62.

    Article  CAS  PubMed  Google Scholar 

  100. Rubinstein E, Lang R. Fungal endocarditis. Eur Heart J. 1995;16(Suppl B):84–9.

    Article  PubMed  Google Scholar 

  101. Karchmer AW. Nosocomial bloodstream infections: organisms, risk factors, and implications. Clin Infect Dis. 2000;31 Suppl 4:S139–43.

    Article  PubMed  Google Scholar 

  102. Keynan Y, et al. Infective endocarditis in the intensive care unit. Crit Care Clin. 2013;29(4):923–51.

    Article  PubMed  Google Scholar 

  103. Martin MV, Yates J, Hitchcock CA. Comparison of voriconazole (UK-109,496) and itraconazole in prevention and treatment of Aspergillus fumigatus endocarditis in guinea pigs. Antimicrob Agents Chemother. 1997;41(1):13–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  104. Bachmann SP, et al. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob Agents Chemother. 2002;46(11):3591–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  105. Bachmann SP, et al. Antifungal combinations against Candida albicans biofilms in vitro. Antimicrob Agents Chemother. 2003;47(11):3657–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  106. Reis LJ, et al. Successful treatment of Aspergillus prosthetic valve endocarditis with oral voriconazole. Clin Infect Dis. 2005;41(5):752–3.

    Article  PubMed  Google Scholar 

  107. Vassiloyanakopoulos A, et al. Aspergillus fumigatus tricuspid native valve endocarditis in a non-intravenous drug user. J Med Microbiol. 2006;55(Pt 5):635–8.

    Article  PubMed  Google Scholar 

  108. Tacke D, Koehler P, Cornely OA. Fungal endocarditis. Curr Opin Infect Dis. 2013;26(6):501–7.

    Article  CAS  PubMed  Google Scholar 

  109. McCormack J, Pollard J. Aspergillus endocarditis 2003–2009. Med Mycol. 2011;49 Suppl 1:S30–4.

    Article  PubMed  Google Scholar 

  110. Tattevin P, et al. Fungal endocarditis: current challenges. Int J Antimicrob Agents. 2014;44(4):290–4.

    Article  CAS  PubMed  Google Scholar 

  111. Kawamura Y, et al. Transfer of Streptococcus adjacens and Streptococcus defectivus to Abiotrophia gen. nov. as Abiotrophia adiacens comb. nov. and Abiotrophia defectiva comb. nov., respectively. Int J Syst Bacteriol. 1995;45(4):798–803.

    Article  CAS  PubMed  Google Scholar 

  112. Giuliano S, et al. Endocarditis caused by nutritionally variant streptococci: a case report and literature review. Infez Med. 2012;20(2):67–74.

    PubMed  Google Scholar 

  113. Collins MD, Lawson PA. The genus Abiotrophia (Kawamura et al.) is not monophyletic: proposal of Granulicatella gen. nov., Granulicatella adiacens comb. nov., Granulicatella elegans comb. nov. and Granulicatella balaenopterae comb. nov. Int J Syst Evol Microbiol. 2000;50(Pt 1):365–9.

    Article  CAS  PubMed  Google Scholar 

  114. Cargill JS, et al. Granulicatella infection: diagnosis and management. J Med Microbiol. 2012;61(Pt 6):755–61.

    Article  PubMed  Google Scholar 

  115. Yang YS, et al. A ruptured cerebral mycotic aneurysm caused by Abiotrophia defectiva endocarditis. Am J Med Sci. 2010;339(2):190–1.

    Article  PubMed  Google Scholar 

  116. Ratcliffe P, et al. Comparison of MALDI-TOF MS and VITEK 2 system for laboratory diagnosis of Granulicatella and Abiotrophia species causing invasive infections. Diagn Microbiol Infect Dis. 2013;77(3):216–9.

    Article  CAS  PubMed  Google Scholar 

  117. Zheng X, et al. Antimicrobial susceptibilities of invasive pediatric Abiotrophia and Granulicatella isolates. J Clin Microbiol. 2004;42(9):4323–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  118. Henry NK, et al. Antimicrobial therapy of experimental endocarditis caused by nutritionally variant viridans group streptococci. Antimicrob Agents Chemother. 1986;30(3):465–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  119. Habib G, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009;30(19):2369–413.

    Article  PubMed  Google Scholar 

  120. Liu A, et al. Tuberculous endocarditis. Int J Cardiol. 2013;167(3):640–5.

    Article  PubMed  Google Scholar 

  121. Cope AP, Heber M, Wilkins EG. Valvular tuberculous endocarditis: a case report and review of the literature. J Infect. 1990;21(3):293–6.

    Article  CAS  PubMed  Google Scholar 

  122. Spell DW, et al. Native valve endocarditis due to Mycobacterium fortuitum biovar fortuitum: case report and review. Clin Infect Dis. 2000;30(3):605–6.

    Article  CAS  PubMed  Google Scholar 

  123. Corrales-Medina V, et al. Native valve endocarditis caused by rapidly growing mycobacteria: case report and review of the literature. Scand J Infect Dis. 2007;39(6–7):639–41.

    Article  PubMed  Google Scholar 

  124. Olalla J, et al. Mycobacterium fortuitum complex endocarditis-case report and literature review. Clin Microbiol Infect. 2002;8(2):125–9.

    Article  CAS  PubMed  Google Scholar 

  125. Bush LM, et al. Mycobacterial prosthetic valve endocarditis. Curr Infect Dis Rep. 2010;12(4):257–65.

    Article  PubMed  Google Scholar 

  126. Cohen JI, et al. Prosthetic valve endocarditis caused by Mycoplasma hominis. Am J Med. 1989;86(6 Pt 2):819–21.

    Article  CAS  PubMed  Google Scholar 

  127. Popat K, Barnardo D, Webb-Peploe M. Mycoplasma pneumoniae endocarditis. Br Heart J. 1980;44(1):111–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  128. Jamil HA, et al. Late-onset prosthetic valve endocarditis caused by Mycoplasma hominis, diagnosed using broad-range bacterial PCR. J Med Microbiol. 2012;61(Pt 2):300–1.

    Article  CAS  PubMed  Google Scholar 

  129. Boussier R, et al. Two-step bacterial broad-range polymerase chain reaction analysis of heart valve tissue improves bacteriological diagnosis of infective endocarditis. Diagn Microbiol Infect Dis. 2013;75(3):240–4.

    Article  CAS  PubMed  Google Scholar 

  130. Fenollar F, et al. Mycoplasma endocarditis: two case reports and a review. Clin Infect Dis. 2004;38(3):e21–4.

    Article  PubMed  Google Scholar 

  131. Hussain ST, et al. Mycoplasma hominis prosthetic valve endocarditis: the value of molecular sequencing in cardiac surgery. J Thorac Cardiovasc Surg. 2013;146(1):e7–9.

    Article  PubMed  Google Scholar 

  132. McCabe RE, et al. Prosthetic valve endocarditis caused by Legionella pneumophila. Ann Intern Med. 1984;100(4):525–7.

    Article  CAS  PubMed  Google Scholar 

  133. Tompkins LS, et al. Legionella prosthetic-valve endocarditis. N Engl J Med. 1988;318(9):530–5.

    Article  CAS  PubMed  Google Scholar 

  134. Park D, Pugliese A, Cunha BA. Legionella micdadei prosthetic valve endocarditis. Infection. 1994;22(3):213–5.

    Article  CAS  PubMed  Google Scholar 

  135. Chen TT, Schapiro JM, Loutit J. Prosthetic valve endocarditis due to Legionella pneumophila. J Cardiovasc Surg (Torino). 1996;37(6):631–3.

    CAS  Google Scholar 

  136. Fukuta Y, et al. Legionella micdadei prosthetic valve endocarditis complicated by brain abscess: case report and review of the literature. Scand J Infect Dis. 2012;44(6):414–8.

    Article  CAS  PubMed  Google Scholar 

  137. Massey R, Kumar P, Pepper JR. Innocent victim of a localised outbreak: legionella endocarditis. Heart. 2003;89(5):e16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  138. Leggieri N, et al. Legionella longbeachae and endocarditis. Emerg Infect Dis. 2012;18(1):95–7.

    Article  PubMed  PubMed Central  Google Scholar 

  139. Pearce MM, et al. Native valve endocarditis due to a novel strain of Legionella. J Clin Microbiol. 2011;49(9):3340–2.

    Article  PubMed  PubMed Central  Google Scholar 

  140. Sabria M, et al. Fluoroquinolones vs macrolides in the treatment of Legionnaires disease. Chest. 2005;128(3):1401–5.

    Article  CAS  PubMed  Google Scholar 

  141. Blazquez Garrido RM, et al. Antimicrobial chemotherapy for Legionnaires disease: levofloxacin versus macrolides. Clin Infect Dis. 2005;40(6):800–6.

    Article  PubMed  Google Scholar 

  142. Mykietiuk A, et al. Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy. Clin Infect Dis. 2005;40(6):794–9.

    Article  CAS  PubMed  Google Scholar 

  143. Fenollar F, Lepidi H, Raoult D. Whipple’s endocarditis: review of the literature and comparisons with Q fever, Bartonella infection, and blood culture-positive endocarditis. Clin Infect Dis. 2001;33(8):1309–16.

    Article  CAS  PubMed  Google Scholar 

  144. Richardson DC, et al. Tropheryma whippelii as a cause of afebrile culture-negative endocarditis: the evolving spectrum of Whipple’s disease. J Infect. 2003;47(2):170–3.

    Article  PubMed  Google Scholar 

  145. Herrmann MD, et al. Isolated Whipple’s endocarditis: an underestimated diagnosis that requires molecular analysis of surgical material. Ann Thorac Surg. 2014;98(1):e1–3.

    Article  PubMed  Google Scholar 

  146. Steiner I. Nonbacterial thrombotic endocarditis – a study of 171 case reports. Cesk Patol. 1993;29(2):58–60.

    CAS  PubMed  Google Scholar 

  147. Scantlebury DC, Nkomo VT, Enriquez-Sarano M. Antiphospholipid syndrome and recurrent thrombotic valve disease. J Am Coll Cardiol. 2013;61(23):e177.

    Article  PubMed  Google Scholar 

  148. Geri G, et al. Spectrum of cardiac lesions in Behcet disease: a series of 52 patients and review of the literature. Medicine (Baltimore). 2012;91(1):25–34.

    Article  Google Scholar 

  149. Libman E, Sacks B. A hitherto undescribed form of valvular and mural endocarditis. Arch Intern Med. 1924;33:701–37.

    Article  Google Scholar 

  150. Wang LW, et al. Antiphospholipid syndrome: an important differential diagnosis for culture-negative endocarditis. Am J Med. 2015;128:250–3.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Thomas J. Marrie MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing

About this chapter

Cite this chapter

Keynan, Y., Smith, S., Marrie, T.J. (2016). Blood Culture Negative Endocarditis. In: Chan, KL., Embil, J. (eds) Endocarditis. Springer, Cham. https://doi.org/10.1007/978-3-319-27784-4_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-27784-4_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-27782-0

  • Online ISBN: 978-3-319-27784-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics